RESTORING A BALANCED IMMUNE SYSTEM
In the area of immunology, LFB offers therapeutic solutions for managing patient with primary immunodeficiency (PID), autoimmune diseases including immune-mediated neuropathy, and acquired disorders such as secondary immunodeficiency (SID).
Chronic treatment for these disorders exploits a mechanism of immunoglobulin replacement (for antibody deficiency) or immunomodulation (in autoimmune diseases).
LFB produces and markets two polyvalent human immunoglobulins.
For managing special conditions, LFB manufactures and markets specific immunoglobulins intended for treating a particular target, such as Clostridium tetani.